Benjamin Woesthoff

Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients.

LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.

Union Investment Real Estate GmbH (Union Investment) is the real estate fund management subsidiary of Union Asset Management Holding AG in Germany. The Union Investment group is an affiliate of the FinanzVerbund der Volksbanken Raiffeisenbanken, the Raiffeisen credit union network. Headquartered in Hamburg, Union Investment was founded in 1965 and manages a range of open-ended real estate funds, comprising institutional and retail products. The funds are distributed throughout Germany by regional cooperative banks.

Triodos Bank NV provides commercial banking and lending services to cultural, social, and environmental organizations. It offers personal and business banking services including loans, overdrafts, current, saving, deposit, and reserve accounts. The firm focuses on the renewable energy, social housing, healthcare, fair trade, organic food, farming, and social development fields. The company was founded in 1968 and is headquartered in Utrecht, the Netherlands.

AlpInvest Partners, Inc. (AlpInvest) is the New York City private equity subsidiary of Netherlands-based AlpInvest Partners BV, ultimately held by The Carlyle Group LP (NASDAQ: CG). Established in 1999 as NIB Capital Private Equity, the firm became AlpInvest Partners in 2004. They were the first exclusive private equity manager for a public pension fund and invest worldwide across primary funds, secondaries, and direct investment (co-investment) channels, covering the entire private equity spectrum. In addition to the New York office, AlpInvest has offices in Amsterdam, Hong Kong and London. They are a socially responsible investor which works to promote sustainability and governance as an important factor in investment choices. They are a signatory to the UN Principles for Responsible Investments and exclude direct investments in companies that are directly involved in the manufacturing or distribution of products that clearly violate Dutch and relevant international conventions. They also explore sustainability-themed investments.

Robeco Private Equity is one of the private equity divisions within Robeco Alternative Investments which is the alternative investment division of Robeco Institutional Asset Management BV, a European investment manager founded in 1929 and based in Rotterdam with offices and teams in Europe, the US, the Middle East and Asia. In 2001 Robeco became part of the privately-owned Rabobank group (also known as Coöperatieve Centrale Raifeissen-Boerenleenbank BA). In late 2006 Robeco established a strategic alliance for sustainable investing with the Swiss-based group SAM-Sustainable Asset Management. Based in Rotterdam, Robeco Private Equity pursues the group's mainstream private equity activities, primarily fund-of-fund management and sector-specialized structured products. They also have a presence in New York. Their clients are institutions and private individuals. Robeco's private equity team started managing funds-of-funds in 2001 and pioneered ESG-focused FoF in 2004. They reorganized mid-2009 when part of the team relocated to Zurich to cooperate closely with SAM. The Switzerland-based team focuses on the clean tech and sustainable sectors, as well as on direct private equity investments.

ING Bank NV (Broker) (ING Bank-Broker) is the broker-dealer division of ING Bank NV, an investment bank headquartered in Amsterdam, Netherlands. It is a wholly-owned subsidiary of ING Groep N.V. (AMS: INGA; NYSE: ING), a Dutch multinational banking and financial services corporation. The firm was founded in 1991 through the merger of Nationale-Nederlanden and NMB Postbank Groep. ING Bank-Broker provides brokerage services to institutions, large corporations, and medium-sized companies.

Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients.

Rivean Capital BV (Rivean Capital) is a private equity subsidiary of Rivean Capital Management Holding BV founded in 1982. The firm is headquartered in Amsterdam, the Netherlands.

AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.

Deloitte Holding BV operates as a financial holding company with interests in consultancy services. The company is headquartered in Rotterdam, the Netherlands.

VeerStichting is a non-profit organization, which engages in the development of the exchange of ideas between students and those who shape society. The company was founded in 1978 and is headquartered in Leiden, Netherlands.

Part of Jones Lang LaSalle, Inc., LaSalle GmbH is a German company that provides professional, scientific and technical services. The company is based in Munich, Germany. The CEOs are Philip la Pierre, René Höpfner, David Ironside. The company was founded in 2002.

Part of Jones Lang LaSalle, Inc., LaSalle Investment Management Kapitalverwaltungsgesellschaft creates investment opportunities that align with the long-term goals of their investors, people, and shareholders. The company is based in Munich, Germany. The German company actively manages the assets they invest in to enhance client returns and build a better world. LaSalle Investment Management is one of the world's leading real estate investment managers across a complete range of investment vehicles. The CEOs are Stefan Pelkofer, Uwe Rempis, Roberto Manuel A. Ato del Avellanal Carrera. The company was founded in 2010.

Mepal BV is a Dutch company that offers a range of clever products for the table, including lunch boxes, dinnerware, storage boxes, and drinking cups. The company is based in Lochem, Netherlands. The company's latest product, Mepal Omnia, is a set of stackable storage containers that can be used to store a variety of food items, such as cereal and cornflakes, helping to keep them fresh for longer. The company was founded in 1950 by Egon Wollf. Rutger de Korte has been the CEO of the company since 1993.

Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.

Het Langeland Ziekenhuis, now known as Haga Hospital Zoetermeer, is a hospital located in Zoetermeer, NL. Patients can access repeat prescriptions, leaflets, and log in to the patient portal, My Langeland, through the Haga Hospital Zoetermeer website. The hospital was renamed after merging with Haga Hospital in The Hague. The hospital's outpatient clinics and blood collection locations are closed on holidays, but the emergency department and GP station remain open. Haga Hospital is currently investigating the future of birth care in Zoetermeer. The hospital also hosts information evenings on breastfeeding and prostate health.

Risun Holding Co. Ltd. is a Chinese chemical company that produces a variety of chemical products including coal tar, benzene, methanol, crude phenol, and industrial naphthalene. The private company is based in Beijing, China. The company was founded in 2004 and the CEO is Feng Shi.

Both Ends operates as a non-profit organization focused on poverty reduction and improvement of environmental governance. The non-profit company is based in Amsterdam, the Netherlands.

nexeye BV operates as a financial holding company with interests in eyewear. The company is headquartered in Gorinchem, the Netherlands.

The National Museum of Ethnology operates a museum. The private company is based in Leiden, Netherlands.

Langeland Ziekenhuis operates hospitals.

Framework Venture Partners is a venture capital firm founded in 2018 by Peter Misek and Andrew Lugsdin. The firm is headquartered in Canada.

Leiderdorp Instruments BV engages in the development, manufacture and sale of industrial equipment. It offers measurement, groundwater management, (solar)energy monitoring, and amplifying devices. The company was founded in 1987 AND is headquartered in Leiderdorp, the Netherlands.

Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022.

Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA.

Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist.

EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.